Available Technologies

Find technologies available for licensing from UC Irvine.

No technologies match these criteria.
Schedule UC TechAlerts to receive an email when technologies are published that match this search. Click on the Save Search link above

Depletion and Replacement of Brain Border Myeloid Cells

A novel method for selectively targeting and modulating brain border-associated myeloid cells for the treatment of neurological disorders.

Engineered TNA Polymerase for Therapeutic Applications

An engineered polymerase enabling the synthesis of threose nucleic acid (TNA) for advanced therapeutic applications.

REVEALR Technology for Viral Detection

A novel diagnostic technology offering rapid, accurate, and inexpensive detection, genotyping, and quantification of viral RNA in patient-derived samples, enhancing public health capabilities.

System And Methods For Acoustic Monitoring Of Electron Radiotherapy

A novel technology for real-time, non-invasive monitoring and adaptive control of electron radiotherapy treatments using acoustic signals.

Advanced Vaccine Technology: Lipid Nanoparticle Adjuvants

This technology represents a pioneering approach to vaccine development, focusing on encapsulated adjuvants and antigens to enhance efficacy while minimizing side effects.

Orthogonal Redox Cofactor for Enhanced Biomanufacturing Flexibility

Introducing a groundbreaking orthogonal redox cofactor, NMN+, to revolutionize redox reaction control in biomanufacturing.

Microfluidic Platform for Sorting Plant Cells

A novel dielectrophoresis (DEP)-based microfluidics method for efficient and label-free sorting of plant cells, leveraging unique dielectric properties.

AI-Powered Trabecular Meshwork Identification for Glaucoma Surgeries

A revolutionary software that integrates with surgical microscopes to accurately locate the trabecular meshwork (TM), enhancing the safety and efficiency of glaucoma surgeries.


5270 California Avenue / Irvine,CA
92697-7700 / Tel: 949.824.2683
  • Facebook
  • Twitter
  • Twitter
  • Twitter
  • Twitter